Skip to main content

Table 1 Tumor characteristics and preexisting kidney disease in patients with renal cell carcinoma

From: Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Case

Size (mm)

Primary tumor

Tumor location

Baseline CKD stage

First line treatment /

Preexisting kidney disease

#1

32

cT1a/DD metastasis

close to renal pelvis

3b

Nephrectomy, RFA and embolisation ipsilateral

#2

30

cT1a/DD metastasis

mid pole

2

Nephrectomy, partial resection ipsilateral /DM type 2

#3

14

10

cT1a

upper pole

mid pole

3b

Nephrectomy, partial resection ipsilateral / short term dialysis, DM type 2

#4

26

cT1a

upper pole

2

RPGN, kidney transplant

#5

70

cT3a

infiltrating renal vein

2

Partial resection contralateral

#6

36

cT1a

mid pole

4

Nephrectomy

#7

36

cT1a

lower pole

3a

partial resection contralateral, multiple RFA ipsilateral / VHL

#8

39

cT1a

close to renal pelvis

3a

partial resection ipsi- and contralateral / VHL

#9

47

cT3a

extends to perinephric tissue

3b

#10

9

10

15

cT3a/DD metastasis

lower pole

extends to perinephric tissue

close to hilum

3b

Nephrectomy, partial resection ipsilateral

  1. RFA Radiofrequency ablation, CKD chronic kidney disease, DM diabetes mellitus, RPGN rapidly progressive glomerulonephritis, VHL von Hippel-Lindau disease